Tag

Scalability

Whac-A-Mole: Proactive and Personalized Solutions to HR’s Biggest Challenges
HUMAN RESOURCES, VIDEO, HUMAN RESOURCES

Whac-A-Mole: Proactive and Personalized Solutions to HR’s Biggest Challenges

Being an HR leader often feels like a giant game of Whac-A-Mole. You solve one problem, then another one pops up, then another…then another.

Faced with ever-evolving employee expectations, HR leaders need to innovate in 2024 and beyond to meet the diverse needs of their workforce. If you can craft a people strategy which offers employees a high degree of personalization and flexibility, you don’t just get ahead of the game – you win it.

Continue reading
Expanding Scalability Potential of T-Cell Therapies with Allogeneic Approaches
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Expanding Scalability Potential of T-Cell Therapies with Allogeneic Approaches

Amy has been at Atara Biotherapeutics for 5 years. She is currently the Vice President of Manufacturing, which includes External Manufacturing, Material Sciences, and Manufacturing Science and Technology functions. Prior to her current role, she led the joint team that transitioned the commercialization of the first approved allogeneic T-cell therapy to Atara’s strategic partner, Pierre Fabre.

Continue reading
Unleashing the Potential: Leading the Future of Biologics Market Supply
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Unleashing the Potential: Leading the Future of Biologics Market Supply

Dave Stewart, Senior Vice President Operational and Process Technology, Large-Scale Business Unit, is a proven leader in the biologics manufacturing industry, with a focus on building diverse, multi-disciplinary teams that drive customer deliverables. He brings a servant-leadership mindset and more than two decades of biotech leadership experience to cultivate accountability, collaboration and agility – assembling engaged, high-performing teams and partnerships built on trust. Dave is responsible for ensuring a consistent operations and equipment model, performance and incorporating emerging capabilities across the large-scale network at FUJIFILM Diosynth Biotechnologies (FDB) and is a key driver in building the world’s largest and most tightly connected CDMO network.

Continue reading